KALA · Categories · Form 4

KALA - SEC Form 4 insider transactions

KALA BIO Inc. (KALA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KALA

• 169d
  SEC Form 4 filed by Chief Executive Officer Lazar David E.

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 195d
  SEC Form 4 filed by Chief Executive Officer Lazar David E.

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 228d
  CHIEF FINANCIAL OFFICER Reumuth Mary sold $27,544 worth of shares (33,197 units at $0.83), decreasing direct ownership by 53% to 28,906 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 228d
  Director Iwicki Mark T sold $125,464 worth of shares (154,894 units at $0.81), decreasing direct ownership by 60% to 103,540 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 228d
  CHIEF BUSINESS OFFICER Kharabi Darius sold $17,269 worth of shares (20,806 units at $0.83), decreasing direct ownership by 33% to 41,760 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 228d
  Director Bazemore Todd sold $39,647 worth of shares (47,768 units at $0.83), decreasing direct ownership by 57% to 35,932 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 228d
  Officer Brazzell Romulus K sold $38,801 worth of shares (46,748 units at $0.83), decreasing direct ownership by 57% to 35,952 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 250d
  Former 10% owner Baker Bros. Advisors Lp sold $1,056,722 worth of shares (730,408 units at $1.45) (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 280d
  SEC Form 4 filed by Officer Bazemore Todd

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 348d
  CHIEF BUSINESS OFFICER Kharabi Darius sold $18,089 worth of shares (4,511 units at $4.01), decreasing direct ownership by 7% to 62,566 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 348d
  Officer Bazemore Todd sold $16,273 worth of shares (4,058 units at $4.01), decreasing direct ownership by 5% to 83,699 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 348d
  CHIEF FINANCIAL OFFICER Reumuth Mary sold $14,560 worth of shares (3,631 units at $4.01), decreasing direct ownership by 6% to 62,100 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 348d
  Director Iwicki Mark T sold $53,040 worth of shares (13,227 units at $4.01), decreasing direct ownership by 5% to 258,433 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 348d
  Officer Brazzell Romulus K sold $21,057 worth of shares (5,251 units at $4.01), decreasing direct ownership by 6% to 82,698 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Rosen Howard B was granted 2,450 shares, increasing direct ownership by 18% to 16,240 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Iwicki Mark T was granted 2,450 shares, increasing direct ownership by 0.91% to 271,660 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Farid Marjan was granted 2,450 shares, increasing direct ownership by 31% to 10,242 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Perry Gregory D was granted 2,450 shares, increasing direct ownership by 22% to 13,344 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Myers C. Daniel was granted 2,450 shares, increasing direct ownership by 31% to 10,374 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 357d
  Director Koven Andrew I was granted 3,050 shares, increasing direct ownership by 22% to 16,972 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 369d
  Amendment: Director Iwicki Mark T sold $40,639 worth of shares (10,866 units at $3.74), decreasing direct ownership by 4% to 269,210 units (SEC Form 4)

  4/A - KALA BIO, Inc. (0001479419) (Issuer)
• 370d
  CHIEF BUSINESS OFFICER Kharabi Darius sold $2,730 worth of shares (730 units at $3.74), decreasing direct ownership by 1% to 67,077 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 370d
  CHIEF FINANCIAL OFFICER Reumuth Mary sold $10,659 worth of shares (2,850 units at $3.74), decreasing direct ownership by 4% to 65,731 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 370d
  Officer Brazzell Romulus K sold $13,789 worth of shares (3,687 units at $3.74), decreasing direct ownership by 4% to 87,949 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 370d
  Director Iwicki Mark T increased direct ownership by 4% to 269,210 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 370d
  Officer Bazemore Todd sold $12,679 worth of shares (3,390 units at $3.74), decreasing direct ownership by 4% to 87,757 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 456d
  SEC Form 4 filed by Officer Bazemore Todd

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 515d
  Amendment: SEC Form 4 filed by Officer Brazzell Romulus K

  4/A - KALA BIO, Inc. (0001479419) (Issuer)
• 518d
  Officer Bazemore Todd was granted 10,100 shares and sold $15,207 worth of shares (1,993 units at $7.63), increasing direct ownership by 10% to 91,147 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 518d
  CHIEF BUSINESS OFFICER Kharabi Darius was granted 10,100 shares and sold $15,420 worth of shares (2,021 units at $7.63), increasing direct ownership by 14% to 67,807 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 518d
  Officer Brazzell Romulus K was granted 10,100 shares and sold $18,663 worth of shares (2,446 units at $7.63), increasing direct ownership by 9% to 92,418 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 518d
  CHIEF EXECUTIVE OFFICER Iwicki Mark T was granted 22,100 shares and sold $44,094 worth of shares (5,779 units at $7.63), increasing direct ownership by 6% to 280,076 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 518d
  CHIEF FINANCIAL OFFICER Reumuth Mary was granted 10,100 shares and sold $13,017 worth of shares (1,706 units at $7.63), increasing direct ownership by 14% to 68,581 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 712d
  CHIEF EXECUTIVE OFFICER Iwicki Mark T sold $72,048 worth of shares (15,168 units at $4.75), decreasing direct ownership by 5% to 263,755 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 712d
  CHIEF BUSINESS OFFICER Kharabi Darius sold $24,500 worth of shares (5,158 units at $4.75), decreasing direct ownership by 8% to 59,728 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 712d
  Officer Bazemore Todd sold $22,102 worth of shares (4,653 units at $4.75), decreasing direct ownership by 5% to 83,040 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 712d
  CHIEF FINANCIAL OFFICER Reumuth Mary sold $19,774 worth of shares (4,163 units at $4.75), decreasing direct ownership by 6% to 60,187 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 712d
  Officer Brazzell Romulus K sold $26,073 worth of shares (5,489 units at $4.75), decreasing direct ownership by 6% to 83,982 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Farid Marjan was granted 1,400 shares, increasing direct ownership by 22% to 7,792 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Myers C. Daniel was granted 1,400 shares, increasing direct ownership by 21% to 7,924 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Perry Gregory D was granted 1,400 shares, increasing direct ownership by 15% to 10,894 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Koven Andrew I was granted 1,750 shares, increasing direct ownership by 14% to 13,922 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Rosen Howard B was granted 1,400 shares, increasing direct ownership by 11% to 13,887 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 727d
  Director Blumenkranz Mark S. was granted 1,400 shares, increasing direct ownership by 12% to 13,091 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 736d
  Kharabi Darius sold $1,407 worth of shares (231 units at $6.09), decreasing direct ownership by 0.35% to 64,886 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 736d
  Bazemore Todd sold $12,746 worth of shares (2,093 units at $6.09), decreasing direct ownership by 2% to 87,693 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 736d
  Reumuth Mary sold $10,877 worth of shares (1,786 units at $6.09), decreasing direct ownership by 3% to 64,350 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 736d
  Iwicki Mark T sold $45,017 worth of shares (7,392 units at $6.09), decreasing direct ownership by 3% to 278,923 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 736d
  Brazzell Romulus K sold $12,192 worth of shares (2,002 units at $6.09), decreasing direct ownership by 2% to 89,471 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Trachtenberg Eric was granted 4,600 shares and sold $8,270 worth of shares (1,227 units at $6.74), increasing direct ownership by 5% to 68,066 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Kharabi Darius was granted 4,600 shares and sold $9,321 worth of shares (1,385 units at $6.73), increasing direct ownership by 5% to 65,117 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Brazzell Romulus K was granted 6,500 shares and sold $10,899 worth of shares (1,617 units at $6.74), increasing direct ownership by 6% to 91,473 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Iwicki Mark T sold $30,547 worth of shares (4,539 units at $6.73) and was granted 14,300 shares, increasing direct ownership by 4% to 286,315 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Reumuth Mary was granted 4,600 shares and sold $8,270 worth of shares (1,227 units at $6.74), increasing direct ownership by 5% to 66,136 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 886d
  Bazemore Todd sold $9,470 worth of shares (1,405 units at $6.74) and was granted 6,500 shares, increasing direct ownership by 6% to 89,786 units (SEC Form 4)

  4 - KALA BIO, Inc. (0001479419) (Issuer)
• 1082d
  SEC Form 4 filed by Kharabi Darius

  4 - Kala Pharmaceuticals, Inc. (0001479419) (Issuer)
• 1082d
  SEC Form 4 filed by Rosen Howard B

  4 - Kala Pharmaceuticals, Inc. (0001479419) (Issuer)
• 1082d
  SEC Form 4 filed by Koven Andrew I

  4 - Kala Pharmaceuticals, Inc. (0001479419) (Issuer)
• 1082d
  SEC Form 4 filed by Myers C. Daniel

  4 - Kala Pharmaceuticals, Inc. (0001479419) (Issuer)
• 1082d
  SEC Form 4 filed by Farid Marjan

  4 - Kala Pharmaceuticals, Inc. (0001479419) (Issuer)

Other KALA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends